References
1. Barton M, Hawkes M, Moore D, Conly J, Nicolle L, Allen U et al. Guidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus: A perspective for Canadian health care practitioners. Can J Infect Dis Med Microbiol 2006; 17(Suppl C): 4C- 24C.
2. Blondel-Hill E. & Fryters S. (2012). Bugs and Drugs: An Antimicrobial/Infectious Diseases Reference. Edmonton, Alberta: Alberta Health Services, 2012.
3. Centre for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus (MRSA) Infections. Retrieved online at: http://www.cdc.gov/mrsa/
4. Health Canada. (2007). Guidance Document: Disinfectant Drugs. Retried online at http://www.hc-sc.gc.ca/dhp-mps/prodpharma/applic-demande/guide-ld/disinfect-desinfect/disinf_desinf-eng.php
5. Marra F, Patrick DM, Chong M, McKay R, Hoang L, Bowie WR. Population-based study of the increased incidence of skin and soft tissue infection and associated antimicrobial use, Antimicrobial Agents and Chemotherapy 2012; 56(12): 6243-6249.
6. Provincial Infection Control Network of British Columbia. (2012). Methicillin-Resistant Staphylococcus aureus (MRSA) Surveillance Report. Retrieved online at: http://www.picnet.ca/uploads/files/surveillance/MRSA%20Annual%20Surveillance%20Report%202011-2012.pdf
7. Popovich KJ, Hota B. Treatment and prevention of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections, Dermatologic Therapy 2008;21: 167-179.
8. Klein EY, Sun L, Smith DL, Laxminarayan R. The changing epidemiology of methicillin-resistant Staphylococcus aureus in the United States: a national observational study. Am J Epidemiol 2013;177:666-674.
9. Smith CH, Goldman RD. Staphylococcus aureus decolonization for recurrent skin and soft tissue infections in children. Can Fam Physician 2012;58:1350-1352.
10. Golding GR, Quinn B, Bergstrom K, Stockdale D, Woods S, Nsungu M, Brooke B, Levett PN, Horsman G, McDonald R, Szklarczuk B, Silcox S, Paton S, Carson M, Mulvey MR, Irvine J; Northern Antibiotic Resistance Partnership.Community-based educational intervention to limit the dissemination of community-associated methicillin-resistant Staphylococcus aureus in Northern Saskatchewan, Canada. BMC Public Health 2012;12:15.
11. Stenstrom R, Grafstein E, Romney M, Fahimi J, Harris D, Hunte G, Innes G, Christenson J.Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus skin and soft tissue infection in a Canadian emergency department. Can Journal Emergency Med. 2009 Sep;11(5):430-438.
12. Dantes R, Mu Y, Belflower R, Aragon D, Dumyati G, Harrison LH, Lessa FC, Lynfield R, Nadle J, Petit S, Ray SM, Schaffner W, Townes J, Fridkin S; Emerging Infections Program–Active Bacterial Core Surveillance MRSA Surveillance Investigators. National Burden of Invasive Methicillin-Resistant Staphylococcus aureus Infections, United States, 2011. JAMA Intern Med 2013;173(21):1970-1978.